Sensyne Health PLC
LSE:SENS
Sensyne Health PLC
LSE:SENS
Price:
0.35 GBX
-33.33%
Market Closed
Updated:
May 1, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of SENS.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SENS
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
SENS Competitors Multiples
Sensyne Health PLC Competitors
Sensyne Health PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Sensyne Health PLC
LSE:SENS
|
576.8k GBP | 0.1 | -0 | 0.2 | 0.2 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.3B USD | 13.5 | 60.9 | 61.3 | 65.9 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.6B AUD | 79.6 | 166.9 | 114.8 | 114.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.9 | 24.8 | 12.9 | 14.6 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.2B USD | 11.4 | -337.7 | -180.3 | -167.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.7 | 32.9 | 22.1 | 23.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.2B SEK | 25.8 | 99.5 | -65.5 | -65.5 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -22.2 | 25.8 | 275 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.7 | -315.5 | 33.5 | -109.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
